111315 ⎘
ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV Virus like particles [VLP]
MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#2COMPOSITIONS COMPRISING MODIFIED FLAVIVIRUS E GLYCOPROTEINS AND METHODS OF MAKING AND USING THE SAME
#3NUCLEIC ACID COMPOSITIONS FOR DELIVERING EXOGENOUS POLYNUCLEOTIDES AND METHODS OF USE
#4METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT
#5METHODS AND COMPOSITIONS FOR MATURE DENGUE VIRUSES AS VACCINES AND DIAGNOSTICS
#6BROADLY REACTIVE IMMUNOGENS OF DENGUE VIRUS, COMPOSITIONS, AND METHODS OF USE THEREOF
#7METHOD FOR REMOVING HOST CELL DNA FROM VIRUS PREPARATION
#8DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#9DNA MOLECULES PRODUCING CUSTOM DESIGNED REPLICATING AND NON-REPLICATING NEGATIVE STRANDED RNA VIRUSES AND USES THERE OF
#10METHOD FOR REMOVING HOST CELL DNA FROM VIRUS PREPARATION
#11METHODS FOR DETERMINING ANTIBODY AFFINITY AND BINDING KINETICS USING VLPS OR LIVE VIRUSES ATTACHED TO BIOSENSORS
#12METHODS AND COMPOSITIONS FOR STABILIZED RECOMBINANT FLAVIVIRUS E PROTEIN DIMERS
#13Multivalent Virus Like Particle Vaccines
#14BROADLY REACTIVE IMMUNOGENS OF DENGUE VIRUS, COMPOSITIONS, AND METHODS OF USE THEREOF
#15Mature virus-like particles of flaviviruses
#16Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays
#17Chimeric viruses encoding mutant zika virus envelope glycoproteins
#18CHIKV RNA vaccines
#19METHODS AND COMPOSITIONS FOR ZIKA VIRUS DETECTION
#20Recombinant measles virus expressing zika virus prM and E proteins
#21Lentiviral vector-based Japanese encephalitis immunogenic composition
#22METHODS AND COMPOSITIONS FOR RECOMBINANT DENGUE VIRUSES FOR VACCINE AND DIAGNOSTIC DEVELOPMENT
#23Methods and compositions for dengue virus serotype 4 epitopes
#24Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
#25ZIKA virus like particle (VLP) based vaccine and microneutralization assay
#26Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
#27Zika virus vaccines
#28Dengue virus-like particle, antibody against dengue virus, and composition comprising the same
#29Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays
#30CHIMERIC DENGUE VIRUS E GLYCOPROTEINS COMPRISING MUTANT DOMAIN I AND DOMAIN II HINGE REGIONS
#31DNA molecules producing custom designed replicating and non-replicating negative stranded RNA viruses and uses there of
#32HIGH POTENCY IMMUNOGENIC COMPOSITIONS
#33Method for producing virus like particles
#34Infectious disease vaccines
#35Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
#36CHIKV RNA vaccines
#37Vaccines against Zika virus based on Zika structure proteins
#38Flavivirus Vaccine
#39High potency immunogenic zika virus compositions
#40Vaccine compositions for treatment of Zika virus
#41Zika RNA vaccines
#42USE OF A LINEAR B CELL EPITOPE OF NS1 PROTEIN TO TREAT DENGUE VIRUS
#43Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
#44Epitope-substituted vaccine for use in improving safety and immunogenicity against dengue viruses
#45Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
#46Lentiviral vector-based Japanese encephalitis immunogenic composition
#47Vaccine compositions against dengue virus diseases
#48Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
#49Novel Flavivirus Antigens
#50Flavivirus virus like particle
#51Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
#52Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
#53Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#54Universal dengue virus sequences and methods of use
#55Recombinant dengue virus antigen comprising the capsid protein leader sequence, full-length prM protein, and full-length E protein
#56Subgenomic replicons of the flavivirus dengue
#57Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#58Subgenomic replicons of the flavivirus dengue
#59Nucleic acids encoding novel chimeric C15/prM/E dengue virus immunogens prepared by DNA shuffling
#60Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
#61Dengue Reporter Virus and Methods of Making and Using the Same
#62Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
#63Flavivirus Replicon Constructs for Tumor Therapy
#64Synthesis and Purification of West Nile Virus Virus-Like Particles
#65Flavivirus vaccine
#66Flavivirus vaccine delivery system
#67Vaccine compositions for treatment of Zika virus